•] Shares CG ONCOLOGY, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • January 18th, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • New York
EMPLOYMENT AGREEMENTEmployment Agreement • January 18th, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This Employment Agreement (this “Agreement”) is made by and between CG Oncology, Inc. (the “Company”), and Corleen Roche (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), effective as of January 16, 2024 (the “Effective Date”).
CG ONCOLOGY, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (AS AMENDED) DATED: July 28, 2023Investors’ Rights Agreement • January 18th, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of July 28, 2023 by and among CG ONCOLOGY, INC., a Delaware corporation (the “Company”), as amended, and the investors listed on Schedule A hereto (each an “Investor” and collectively the “Investors”).
